Aurora Cannabis : Starts Trading on Toronto Stock Exchange

Aurora Cannabis Inc. (the "Company" or "Aurora") (TSXV: ACB) (OTCQX: ACBFF) ( Frankfurt : 21P; WKN: A1C4WM) announced today that common shares of the Company will commence trading on Toronto Stock Exchange (the "TSX") effective Monday July 24 . Common shares will continue to trade under the symbol "ACB".

Legal Cannabis and Hemp Based Product Sales Projected to Grow

According to a research report by Ameri Research Inc., the global legal cannabis market was valued at $14.3 billion in 2016 and is projected to grow at a CAGR of 21.1% from 2017 to 2024. By 2024, the projected demand of cannabis will continue to rise for both recreational and medical use, while reaching an estimated global sales value of $63.5 billion .

Aphria gets price target raise to $13.00 at Clarus Securities

A better than expected quarter has Clarus analyst Noel Atkinson raising his price target on Aphria (TSXV:APH).

On Wednesday, Aphria reported its Q4 and fiscal 2017 results. In the fourth quarter, the company lost $2.6-million on revenue of $5.7-million, a topline that was up 106 per cent over the same period last year.

Kush Bottles Reports Third Quarter Fiscal 2017 Results

SANTA ANA, Calif. Kush Bottles, Inc. (OTCQB: KSHB), a dynamic sales platform that provides unique products and services for both businesses and consumers in the cannabis industry, today reported financial results for its third fiscal quarter ended May 31, 2017 .

Medical Marijuana, Inc. Announces Largest Revenue Quarter and Sales Month in Company History, 269% Revenue Increase From Q2 2016

Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that the second quarter of 2017 generated the largest revenue quarter in the Company's history. Additionally, the Company celebrated the largest-ever single month of revenue in June 2017 as well as the largest sales month and quarter for wholly owned subsidiary Kannaway.

Marapharm Ventures Inc. 'Marapharm' Announces a Private Placement of up to 80 Million Share Purchase Warrants

Marapharm Ventures Inc. (OTCQB: MRPHF) (CSE: MDM.CN) (FSE: 2M0) announces the proposed offering of up to 80 million share purchase warrants. Each warrant will be offered for a consideration of 10 cents (CDN) per warrant for a total of gross proceeds of up to $8 million dollars and are exercisable into one common share for the price of $2.90 per share for a period of 3 years from the date of closing (the "warrants").